+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical PET/MRI

  • Book

  • September 2022
  • Elsevier Science and Technology
  • ID: 5527327

Clinical PET/MR presents the state-of-the-art of PET/MR, guiding the reader from how to scan patients, how to read and report the studies, and how keep an eye on what is clinically relevant for a patient's care. Each chapter starts with the clinical scenario and then moves to pertinent imaging, addressing the need of a clinical PET/MR book written by world experts in both clinical and imaging fields. It discusses the clinical application of PET/MR in diverse subspecialties such as head and neck, neurology, cardiovascular, pediatrics, chest, bone, hematology, breast, hepatobiliary pancreatic, genitourinary, gynecology, and gastrointestinal tract.

This book is a valuable resource for radiologists, oncologists and members of the biomedical field who need to learn more about clinical applications of PET/MR.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Technical aspects2. Contrast agents & radiopharmaceuticals (current, new, future)3. Head and neck (tumors)4. Neuro (epilepsy, degenerative, tumors, etc)5. Cardiovascular (CAD, Fabry, sarcoidosis, myopathies, vasculitis, athero)6. Pediatrics7. Chest (mediastinum, primary lung cancers, mets/nodules)8. Bone (sarcomas, mets, osteomyelitis, diabetic foot)9. Hematology (lymphomas, MM)10. Breast11. Hepatobiliary pancreatic (ccc, hcc, mets, pdac, neuroendocrine)12. GU (adrenals, kidneys, ureters, bladder, postate non treated-bcr)13. GYN14. GI tract (cancers, IBD)

Authors

Onofrio Antonio Catalano Associate Professor, Harvard Medical School, Massachusetts General Hospital, USA. Onofrio Antonio Catalano, MD, PhD, is Associated Professor of Radiology at Harvard Medical School. Dr. Catalano has been working on PET/MR since its first clinical introduction in 2012, at first building the PET/MR program in Naples, Italy, and then at the MGH/Harvard, in Boston, as medical director. He has read thousands of PET/MR scans and is one of the world most prolific researchers on the field of PET/MR. Among several achievements, Dr. Catalano has been the first to demonstrate the utility of PET/MR in the clinical oncologic settings, and the first to show the capabilities of PET/MR in discriminating fibrotic from inflammatory stenoses in Crohn disease patients.